Moderna, Inc. (MRNA)
53.86
-2.40
(-4.26%)
USD |
NASDAQ |
Aug 06, 16:00
54.61
+0.75
(+1.39%)
After-Hours: 06:43
Moderna Price : 53.86 for Aug. 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 06, 2026 | 57.54 | 59.00 | 53.71 | 53.86 | 5.640M |
| Aug 05, 2026 | 58.00 | 59.45 | 55.58 | 56.26 | 5.163M |
| Aug 04, 2026 | 56.84 | 58.34 | 55.88 | 56.99 | 4.000M |
| Aug 03, 2026 | 54.92 | 58.00 | 52.66 | 55.14 | 5.177M |
| Jul 31, 2026 | 57.85 | 59.49 | 54.71 | 54.82 | 7.765M |
| Jul 30, 2026 | 55.96 | 58.08 | 54.52 | 57.92 | 4.458M |
| Jul 29, 2026 | 55.04 | 56.25 | 54.16 | 54.49 | 4.352M |
| Jul 28, 2026 | 54.83 | 55.85 | 53.34 | 55.80 | 5.558M |
| Jul 27, 2026 | 54.75 | 57.07 | 54.39 | 55.63 | 5.040M |
| Jul 24, 2026 | 57.26 | 57.46 | 53.85 | 54.07 | 4.428M |
| Jul 23, 2026 | 57.20 | 58.43 | 56.28 | 57.02 | 4.696M |
| Jul 22, 2026 | 59.52 | 59.86 | 57.74 | 58.07 | 3.780M |
| Jul 21, 2026 | 59.51 | 60.83 | 58.61 | 59.66 | 4.357M |
| Jul 20, 2026 | 61.46 | 62.43 | 59.30 | 59.49 | 4.968M |
| Jul 17, 2026 | 61.68 | 63.28 | 61.06 | 61.82 | 4.552M |
| Jul 16, 2026 | 67.07 | 67.42 | 62.80 | 63.15 | 5.593M |
| Jul 15, 2026 | 67.79 | 68.49 | 65.95 | 68.28 | 3.428M |
| Jul 14, 2026 | 66.67 | 67.89 | 65.80 | 67.44 | 5.812M |
| Jul 13, 2026 | 66.33 | 69.55 | 65.54 | 67.01 | 8.522M |
| Jul 10, 2026 | 76.72 | 76.72 | 67.31 | 68.27 | 9.177M |
| Jul 09, 2026 | 73.80 | 76.84 | 73.14 | 76.56 | 4.415M |
| Jul 08, 2026 | 77.34 | 78.30 | 73.34 | 73.80 | 6.582M |
| Jul 07, 2026 | 82.10 | 82.90 | 77.41 | 79.77 | 8.688M |
| Jul 06, 2026 | 78.55 | 85.60 | 77.50 | 81.80 | 17.30M |
| Jul 02, 2026 | 73.71 | 81.40 | 73.68 | 79.76 | 14.11M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| BioNTech SE | 91.19 |
| Kailera Therapeutics, Inc. | 18.87 |
| Replimune Group, Inc. | 12.86 |
| Sarepta Therapeutics, Inc. | 16.78 |
| Erasca, Inc. | 18.27 |
Price Related Metrics
| PS Ratio | 9.519 |
| PEG Ratio | -1.087 |
| Price to Book Value | 3.178 |
| Earnings Yield | -14.82% |
| Market Cap | 21.49B |
| PEGY Ratio | -1.087 |